Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK PHARMA vs NGL FINE CHM - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GSK PHARMA NGL FINE CHM GSK PHARMA/
NGL FINE CHM
 
P/E (TTM) x 60.6 26.7 226.8% View Chart
P/BV x 22.9 4.2 543.8% View Chart
Dividend Yield % 1.3 0.1 1,355.5%  

Financials

 GSK PHARMA   NGL FINE CHM
EQUITY SHARE DATA
    GSK PHARMA
Mar-24
NGL FINE CHM
Mar-24
GSK PHARMA/
NGL FINE CHM
5-Yr Chart
Click to enlarge
High Rs2,6502,425 109.3%   
Low Rs1,2281,211 101.4%   
Sales per share (Unadj.) Rs203.9548.0 37.2%  
Earnings per share (Unadj.) Rs34.866.9 52.1%  
Cash flow per share (Unadj.) Rs38.985.7 45.4%  
Dividends per share (Unadj.) Rs32.001.75 1,828.6%  
Avg Dividend yield %1.70.1 1,714.5%  
Book value per share (Unadj.) Rs105.5425.0 24.8%  
Shares outstanding (eoy) m169.416.18 2,741.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x9.53.3 286.8%   
Avg P/E ratio x55.727.2 204.8%  
P/CF ratio (eoy) x49.821.2 234.8%  
Price / Book Value ratio x18.44.3 429.9%  
Dividend payout %91.92.6 3,511.5%   
Avg Mkt Cap Rs m328,47411,232 2,924.5%   
No. of employees `000NANA-   
Total wages/salary Rs m6,244451 1,384.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m34,5373,387 1,019.7%  
Other income Rs m1,226141 867.7%   
Total revenues Rs m35,7633,528 1,013.6%   
Gross profit Rs m7,651537 1,423.6%  
Depreciation Rs m697116 598.5%   
Interest Rs m1818 99.4%   
Profit before tax Rs m8,162544 1,499.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,262131 1,726.9%   
Profit after tax Rs m5,900413 1,427.9%  
Gross profit margin %22.215.9 139.6%  
Effective tax rate %27.724.1 115.1%   
Net profit margin %17.112.2 140.0%  
BALANCE SHEET DATA
Current assets Rs m27,9842,127 1,315.9%   
Current liabilities Rs m15,249866 1,761.2%   
Net working cap to sales %36.937.2 99.0%  
Current ratio x1.82.5 74.7%  
Inventory Days Days11570 163.5%  
Debtors Days Days235966 24.3%  
Net fixed assets Rs m6,1191,429 428.3%   
Share capital Rs m1,69431 5,484.2%   
"Free" reserves Rs m16,1722,595 623.1%   
Net worth Rs m17,8662,626 680.3%   
Long term debt Rs m07 0.0%   
Total assets Rs m34,1033,555 959.2%  
Interest coverage x454.731.1 1,463.7%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.01.0 106.3%   
Return on assets %17.412.1 143.1%  
Return on equity %33.015.7 209.9%  
Return on capital %45.821.3 214.5%  
Exports to sales %070.3 0.0%   
Imports to sales %22.913.6 168.9%   
Exports (fob) Rs mNA2,381 0.0%   
Imports (cif) Rs m7,912459 1,722.6%   
Fx inflow Rs m1,3422,409 55.7%   
Fx outflow Rs m7,912509 1,554.7%   
Net fx Rs m-6,5701,900 -345.8%   
CASH FLOW
From Operations Rs m5,820205 2,844.0%  
From Investments Rs m87-268 -32.5%  
From Financial Activity Rs m-5,615-11 51,942.4%  
Net Cashflow Rs m292-74 -393.2%  

Share Holding

Indian Promoters % 0.0 72.7 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 11.7 0.0 58,450.0%  
FIIs % 4.4 0.0 21,800.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 27.3 91.7%  
Shareholders   119,228 14,575 818.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GSK PHARMA With:   DIVIS LABORATORIES    SUN PHARMA    CIPLA    DR. REDDYS LAB    MANKIND PHARMA    


More on GSK Pharma vs NGL FINE CHM

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

GSK Pharma vs NGL FINE CHM Share Price Performance

Period GSK Pharma NGL FINE CHM S&P BSE HEALTHCARE
1-Day 1.86% -0.81% 1.23%
1-Month -6.46% -10.98% -0.24%
1-Year 42.64% -6.78% 43.62%
3-Year CAGR 14.79% -12.77% 20.35%
5-Year CAGR 8.09% 32.89% 26.24%

* Compound Annual Growth Rate

Here are more details on the GSK Pharma share price and the NGL FINE CHM share price.

Moving on to shareholding structures...

The promoters of GSK Pharma hold a 75.0% stake in the company. In case of NGL FINE CHM the stake stands at 72.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of GSK Pharma and the shareholding pattern of NGL FINE CHM.

Finally, a word on dividends...

In the most recent financial year, GSK Pharma paid a dividend of Rs 32.0 per share. This amounted to a Dividend Payout ratio of 91.9%.

NGL FINE CHM paid Rs 1.8, and its dividend payout ratio stood at 2.6%.

You may visit here to review the dividend history of GSK Pharma, and the dividend history of NGL FINE CHM.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising(Closing)

After opening the day higher, Indian benchmark indices remained positive as the session progressed and ended the day on firm footing.